178 related articles for article (PubMed ID: 33893080)
21. The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
Liu Z; Teng L; Gao L; Wang H; Su Y; Li J
Biochem Biophys Res Commun; 2018 Sep; 504(1):6-12. PubMed ID: 30170728
[TBL] [Abstract][Full Text] [Related]
22. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
23. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
[TBL] [Abstract][Full Text] [Related]
24. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
[TBL] [Abstract][Full Text] [Related]
25. Mutational landscape and intra-host diversity of human papillomavirus type 16 long control region and E6 variants in cervical samples.
Escobar-Escamilla N; González-Martínez BE; Araiza-Rodríguez A; Fragoso-Fonseca DE; Pedroza-Torres A; Landa-Flores MG; Garcés-Ayala F; Mendieta-Condado E; Díaz-Quiñonez JA; Castro-Escarpulli G; Ramírez-González JE
Arch Virol; 2019 Dec; 164(12):2953-2961. PubMed ID: 31552532
[TBL] [Abstract][Full Text] [Related]
26. E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature.
Huertas-Salgado A; Martín-Gámez DC; Moreno P; Murillo R; Bravo MM; Villa L; Molano M
Virology; 2011 Feb; 410(1):201-15. PubMed ID: 21130481
[TBL] [Abstract][Full Text] [Related]
27. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
[TBL] [Abstract][Full Text] [Related]
28. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
29. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
Zhu D; Ye M; Zhang W
Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
[TBL] [Abstract][Full Text] [Related]
30. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis.
Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B
Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489
[TBL] [Abstract][Full Text] [Related]
31. Degradation of p53 by natural variants of the E6 protein of human papillomavirus type 16.
Yi JW; Jang M; Kim SJ; Kim SS; Rhee JE
Oncol Rep; 2013 Apr; 29(4):1617-22. PubMed ID: 23404471
[TBL] [Abstract][Full Text] [Related]
32. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
33. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
34. Brd4 inhibition suppresses HPV16 E6 expression and enhances chemoresponse: A potential new target in cervical cancer therapy.
Rataj O; Haedicke-Jarboui J; Stubenrauch F; Iftner T
Int J Cancer; 2019 May; 144(9):2330-2338. PubMed ID: 30421459
[TBL] [Abstract][Full Text] [Related]
35. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
[TBL] [Abstract][Full Text] [Related]
36. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
38. Elevated Expression of Human Papillomavirus-16/18 E6 Oncoprotein Associates with Persistence of Viral Infection: A 3-Year Prospective Study in China.
Yu LL; Kang LN; Zhao FH; Lei XQ; Qin Y; Wu ZN; Wang H; Chen W; Qiao YL
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1167-74. PubMed ID: 27197295
[TBL] [Abstract][Full Text] [Related]
39. HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
Fan Q; Huang T; Sun X; Wang YW; Wang J; Liu Y; Ni T; Gu SL; Li YH; Wang YD
Mol Carcinog; 2021 May; 60(5):313-330. PubMed ID: 33631046
[TBL] [Abstract][Full Text] [Related]
40. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
